Selection of Patients With Chronic Inflammatory Rheumatism Requiring Management During the COVID-19 Pandemia

NCT04806867 | Completed

• 1 other identifier: 87RI20_0044 (SePaRIC)
• Study Type: observational
• Target: 918
• Locations: 1 country
• Sites: 1

Brief Summary

The project proposes to evaluate a strategy for prioritizing teleconsultation for patients with chronic inflammatory rheumatic diseases during the COVID-19 pandemia. This selection will be done through telephone contact by medical students, supervised by residents and rheumatologists on a patient database. The other objectives are to assess the impact of the pandemia on the physical and mental health of patients classified as being at risk

Conditions

Covid19; Inflammatory Rheumatism; Rheumatoid Arthritis; Spondyloarthritis; Inflammatory Arthritis

Keywords

Chronic Inflammatory Rheumatism - COVID-19

Outcome Measures

Primary Outcomes (1)

• Proportion of patients requiring an advice from the referring rheumatologist following the telephone survey.

  Number of request for advice from the referring Rheumatologist by the student and/or the patient

  2 months

Secondary Outcomes (8)

• Evaluate the association between rheumatologist advice asked by student and/or patient and the factors studied

  2 months

• COVID-19 infection evaluation in the monitored patient population

  2 months

• Proportion of patients informed about COVID-19

  2 months

• Evaluate the association between the increase in rheumatic activity perceived by patients and the factors studied

  2 months

• Evaluate the association between pain increase perceived by patients and the factors studied

  2 months

Interventions

SePaRIC-Covid19 cohort OTHER

All patients with Chronic Inflammatory Rheumatism who were contacted by telephone as part of the innovative organizational strategy and who did not object to the use of their data.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with chronic inflammatory rheumatism

You may qualify if:

• Patients with chronic inflammatory rheumatism who answered the RIC-COVID19 survey during the telephone call set up by the Rheumatology Department of the Limoges University Hospital during the confinement.

You may not qualify if:

• Patients objecting to the use of their data

Sponsors & Collaborators

• University Hospital, Limoges: lead

Study Sites (1)

Service de Rhumatologie, CHu de Limoges

Limoges, 87000, France

Location

MeSH Terms

Conditions

COVID-19; Rheumatic Fever; Arthritis, Rheumatoid; Spondylarthritis; Arthritis

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Streptococcal Infections; Gram-Positive Bacterial Infections; Bacterial Infections; Bacterial Infections and Mycoses; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Connective Tissue Diseases; Skin and Connective Tissue Diseases; Autoimmune Diseases; Immune System Diseases; Spondylitis; Spinal Diseases; Bone Diseases

Study Officials

• Pascale PV Vergne-Salle, MD-PhD

  University Hospital, Limoges

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 9, 2020
• First Posted: March 19, 2021
• Study Start: May 1, 2020
• Primary Completion: July 1, 2020
• Study Completion: July 31, 2020
• Last Updated: April 1, 2021

Record last verified: 2021-03

Locations

FR (1)